View TREMFYA® patient before-and-after images by body region

Select Image:

left

right

Week 0

PASIPSSI=45.1

Week 0

Zoom-in icon
(79% PASI improvement) Week 16

PASIPSSI=9.6

(79% PASI improvement) Week 16

Zoom-in icon

(79% PASI improvement)

Photos are representative of an actual TREMFYA® patient from the VISIBLE study at baseline (Week 0) and Week 16.

Images are Janssen-owned from blinded trial: NCT0572150.

*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

Week 0

PASIPSSI=20.1

Week 0

Zoom-in icon
(100% PASI improvement) Week 16

PASIPSSI=0

(100% PASI improvement) Week 16

Zoom-in icon

(100% PASI improvement)

Photos are representative of an actual TREMFYA® patient from the VISIBLE study at baseline (Week 0) and Week 16.

Images are Janssen-owned from blinded trial: NCT0572150.

*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

Week 0

PASIPSSI=20.6

Week 0

Zoom-in icon
(86% PASI improvement) Week 16

PASIPSSI=2.9

(86% PASI improvement) Week 16

Zoom-in icon

(86% PASI improvement)

Photos are representative of an actual TREMFYA® patient from the VISIBLE study at baseline (Week 0) and Week 16.

Images are Janssen-owned from blinded trial: NCT0572150.

*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

Week 0

PASIPSSI=13.8

Week 0

Zoom-in icon
(72% PASI improvement) Week 16

PASIPSSI=3.9

(72% PASI improvement) Week 16

Zoom-in icon

(72% PASI improvement)

Photos are representative of an actual TREMFYA® patient from the VISIBLE study at baseline (Week 0) and Week 16.

Images are Janssen-owned from blinded trial: NCT0572150.

*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

Week 0

PASIPSSI=60

Week 0

Zoom-in icon
(90% PSSI improvement) Week 16

PASIPSSI=6

(90% PSSI improvement) Week 16

Zoom-in icon

(90% PSSI improvement)

Photos are representative of an actual TREMFYA® patient from the VISIBLE study at baseline (Week 0) and Week 16.

Images are Janssen-owned from blinded trial: NCT0572150.

*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

Week 0

PASIPSSI=72

Week 0

Zoom-in icon
(100% PSSI improvement) Week 16

PASIPSSI=0

(100% PSSI improvement) Week 16

Zoom-in icon

(100% PSSI improvement)

Photos are representative of an actual TREMFYA® patient from the VISIBLE study at baseline (Week 0) and Week 16.

Images are Janssen-owned from blinded trial: NCT0572150.

*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

Week 0

PASIPSSI=32.8

Week 0

Zoom-in icon
Week 16

PASIPSSI=8.4

Week 16

Zoom-in icon
Week 48

PASIPSSI=2.8

Week 48

Zoom-in icon

Age:
36

BMI:
31.1 kg/m2

Baseline BSA
involvement:
54%

Psoriasis duration:
12 years

Previous therapies:
topicals, biologics

Plaque psoriasis photos are of a real patient from VOYAGE 2 who received TREMFYA® 100 mg at Weeks 0 and 4, then q8w thereafter through Week 48. Other areas affected (not shown) yielded similar results to those depicted here. Clinical photos shown here are from Week 0, Week 16, and Week 48. Photos are for illustrative purposes only and are used with permission from Janssen Biotech, Inc.

*Individual results may vary.

BMI=body mass index; BSA=body surface area.

Reference: 1. Data on file. Janssen Biotech, Inc.

Week 0

PASIPSSI=

Week 0

Zoom-in icon
Week 4

PASIPSSI=

Week 4

Zoom-in icon
Week 16

PASIPSSI=

Week 16

Zoom-in icon

Photos are representative of an actual TREMFYA® patient at baseline (Week 0), Week 4 and Week 16 outside of clinical trials.

*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

Week 0

PASIPSSI=41.5

Week 0

Zoom-in icon
(96% PASI improvement) Week 16

PASIPSSI=1.6

(96% PASI improvement) Week 16

Zoom-in icon

(96% PASI improvement)

Photos are representative of an actual TREMFYA® patient from the VISIBLE study at baseline (Week 0) and Week 16.

Images are Janssen-owned from blinded trial: NCT0572150.

*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.

Week 0

PASIPSSI=31

Week 0

Zoom-in icon
(100% PASI improvement) Week 16

PASIPSSI=0

(100% PASI improvement) Week 16

Zoom-in icon

(100% PASI improvement)

Photos are representative of an actual TREMFYA® patient from the VISIBLE study at baseline (Week 0) and Week 16.

Images are Janssen-owned from blinded trial: NCT0572150.

*Individual results may vary.

Reference: 1. Data on file. Janssen Biotech, Inc.